COMPANY

VivioMD Group LLC dba VivioMD

Name: VivioMD Group LLC dba VivioMD peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

VivioMD Group LLC dba VivioMD: warning letter recipient for Semaglutide, Tirzepatide, as stated by public registers.

WARNING LETTER RECIPIENT

Received an FDA warning letter naming the peptide.

Semaglutide	False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters
Tirzepatide	False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.